Related Experiment Videos
[4 cases of potassium enteropathy]
Schweizerische Medizinische Wochenschrift
|August 27, 1977
Summary
Oral potassium chloride supplements, used to treat diuretic-induced potassium loss, can cause ischemic enteropathy. This condition involves bowel ulceration or perforation due to KCl
Area of Science:
- Gastroenterology
- Pharmacology
- Cardiovascular Medicine
Background:
- Thiazide diuretics can lead to potassium depletion.
- Potassium chloride (KCl) is commonly prescribed to correct hypokalemia during diuretic therapy.
- Patients often have underlying conditions like hypertension or heart failure, affecting blood vessels.
Observation:
- Four cases of ischemic enteropathy following oral KCl treatment are presented.
- The condition manifested as stenosing ulceration or perforation of the small bowel.
- Both enteric-coated and slow-release KCl formulations were implicated.
Findings:
- Oral KCl can induce ischemic enteropathy, a serious gastrointestinal complication.
- The vaso-active properties of KCl contribute to this iatrogenic condition.
- Pre-existing vascular damage from hypertension or heart failure may increase risk.
Implications:
- Clinicians should consider the risk of ischemic enteropathy when prescribing oral KCl.
- Alternative methods for potassium repletion may be necessary for at-risk patients.
- Awareness of this complication is crucial for patient safety and effective treatment.